Huda Salman: Clinical Trials

3 trials sponsored by Huda Salman, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 suspended, 1 recruiting. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Suspended 2, Recruiting 1

Follow Huda Salman: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Chimeric Antigen Receptor T Cell Redirected to Target CD4 Positive Relapsed Refractory Acute Myeloid Leukemia (AML ) as a Bridge to Allogeneic Stem Cell Transplant
CD4CAR - Acute Myeloid Leukemia
Phase 1SuspendedHuda Salman302024-03-192026-09-30
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
CD4CAR - Chronic Myelomonocytic Leukemia
Phase 1SuspendedHuda Salman302024-02-212026-09-24
CD4CAR for CD4+ Leukemia and Lymphoma
CD4CAR - T-cell Lymphoma, T-cell Leukemia
Phase 1RecruitingHuda Salman202020-07-092026-06-24

Conditions studied

Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Leukemia, T-Cell (1)  ·  Lymphoma (1)  ·  Lymphoma, T-Cell (1)

Countries

United States (3)

Top investigators

Jennifer Schwartz, MD (1)